Yana inganta fitar insulinYana kunna masu karɓar GLP-1 akan ƙwayoyin β-pancreatic, yana haɓaka sakin insulin lokacin da aka haɓaka glucose na jini. Tasirinsa yana raguwa lokacin da matakan glucose suka kasance na al'ada, don haka rage haɗarin hypoglycemia.
Yana hana fitar da glucagon: Yana rage gluconeogenesis na hanta, yana haifar da raguwar matakan glucose na jini mai azumi.
Yana jinkirta zubar ciki: Yana rage saurin shiga cikin ƙananan hanji, ta yadda zai rage yawan hawan glucose na jini bayan cin abinci.
Ciki na tsakiya: Ayyuka akan cibiyar satiety hypothalamic, haɓaka siginar satiety (misali, kunna POMC neurons) da rage yunwa.
Rage cin abinci: Jinkirin zubar da ciki da daidaita sigina na gastrointestinal yana kara rage ci.
Yana inganta bayanin martabar lipid: Yana rage matakan triglyceride kuma yana ƙara yawan lipoprotein (HDL) cholesterol.
Anti-atherosclerosis: Nazarin dabba ya nuna yana iya hana kumburin plaque na jijiyoyin jini, kodayake yana da iyakataccen tasiri akan kafaffen plaques.
Kariyar zuciya: Manyan gwaje-gwaje na asibiti sun tabbatar da ikonsa na rage abubuwan da ke faruwa na zuciya da jijiyoyin jini a cikin marasa lafiya da ciwon sukari da kuma jinkirta ci gaba na rashin lafiyar koda.